Actively Recruiting
Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2024-12-12
50
Participants Needed
1
Research Sites
161 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to identify a dysplasia- and CCA-specific NGS panel to increase the diagnostic sensitivity of histological and/or cytological examination of biliary tract stenosis.
CONDITIONS
Official Title
Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Availability of enough tissue for histological and NGS analysis (at least 20 ng DNA).
- Age greater than/equal to 18 years.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
F
Francecso Vasuri, MD
CONTACT
D
Deborah Malvi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here